The Efficacy and Safety of Neuromodulation Treatments in Late-Life Depression-Reference-Cited by-同舟云学术

The Efficacy and Safety of Neuromodulation Treatments in Late-Life Depression

Published:2020-06-03 Issue:3 Volume:7 Page:337-348
ISSN:2196-3061
Container-title:Current Treatment Options in Psychiatry
language:en
Short-container-title:Curr Treat Options Psych

Author:

van Rooij Sanne J. H.,Riva-Posse Patricio,McDonald William M.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Psychiatry and Mental health,Clinical Psychology

Link

http://link.springer.com/content/pdf/10.1007/s40501-020-00216-w.pdf

Reference81 articles.

1. Riva-Posse P, Hermida AP, McDonald WM. The role of electroconvulsive and neuromodulation therapies in the treatment of geriatric depression. Psychiatr Clin North Am. 2013;36(4):607–30.

2. Iriarte IG, George MS. Transcranial magnetic stimulation (TMS) in the elderly. Curr Psychiatry Rep. 2018;20(1):6.

3. McDonald WM, et al. Electroconvulsive therapy and other neuromodulation therapies. In: Schatzberg AF, Nemeroff CB, editors. Textbook of psychopharmacology. Washington DC: Am Psych Press; 2017. p. 861–99.

4. Group, U.E.R. Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. Lancet. 2003;361(9360):799–808.

5. Rhebergen D, et al. Older age is associated with rapid remission of depression after electroconvulsive therapy: a latent class growth analysis. Am J Geriatr Psychiatry. 2015;23(3):274–82.

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Executive function deficits in patients with the first episode of late‐life depression before and after SSRI treatment: A pilot fMRI study;International Journal of Geriatric Psychiatry;2024-04-30

2. Non-invasive Brain Stimulation in the Management of Suicidal Behavior;Current Behavioral Neuroscience Reports;2024-02-27

3. The association of total pulses with the efficacy of repetitive transcranial magnetic stimulation for treatment-resistant major depression: A dose-response meta-analysis;Asian Journal of Psychiatry;2024-02

4. Converged avenues: depression and Alzheimer’s disease– shared pathophysiology and novel therapeutics;Molecular Biology Reports;2024-01-28

5. Neuromodulation Therapies II: Repetitive Transcranial Magnetic Stimulation and Deep Brain Stimulation;Geriatric Psychiatry;2024